Bridger Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-312,500
Closed -$5.05M 39
2018
Q1
$5.05M Hold
312,500
0.31% 37
2017
Q4
$4.89M Buy
+312,500
New +$4.89M 0.32% 33